1. GeniusByTrade
2. 7senza6
3. cspmedia
4. blackopsstreet
5. TradeChem
1.7senza6 02/01/2018
Allergan to pay Teva Pharm $700 million to settle dispute
2.7senza6 02/09/2018
Risk Assessment Committee (PRAC)
3.zhiggeOS29 10/18/2017
The Biggest Loser: Allergan's Patent Troubles
4.cspmedia 01/24/2018
Morgan Stanley reiterates Buy rating
5.GeniusByTrade 01/10/2018
Allergan Is Set Up for Success in 2018, UBS Says
6.allaccesscompute 10/30/2018
Allergan Shares Lower Despite Q3 Beat, Increased Guidance
7.cspmedia 02/06/2018
Announces Positive Top Line Phase 3 Results for Ubrogepant - an Oral CGRP Receptor Antagonist for the Acute T…
8.barthax 08/03/2018
Spanish pharmaceutical company Almirall said it had agreed to buy five dermatology brands from U.S. company
9.TradeChem 04/30/2018
Mizuho Securities reiterates Hold rating, $185 PT
10.nsinaver 07/19/2018
Releases 'two positive clinical trials, SEQUOIA and CEDAR for abicipar
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW